Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Dogwood Therapeutics, Inc. (NASDAQ: DWTX)
DWTX Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
272.70%
DWTX Stock Analysis
DWTX
PE Ratio:
2.9
DWTX
PEG Ratio:
Not Available
DWTX
Forward EPS Growth (12 month):
0.00%
DWTX
PS Ratio:
DWTX
PSG Ratio:
Not Available
DWTX
Forward Revenue Growth (12 month):
0.00%
DWTX Articles
No data was found